Allogene Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.53
|
|
Average Rating
|
4.11
|
|
# Strong Buys
|
9
|
|
# Buys
|
4
|
|
# Holds
|
5
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.58
|
0.06
|
9.38%
|
|
2022-06-30
|
-0.61
|
-0.52
|
0.09
|
14.75%
|
|
2022-03-31
|
-0.58
|
-0.56
|
0.02
|
3.45%
|
|
2021-12-31
|
-0.60
|
-0.54
|
0.06
|
10.00%
|
|
2021-09-30
|
-0.56
|
-0.57
|
-0.01
|
-1.79%
|
|
2021-06-30
|
-0.55
|
-0.53
|
0.02
|
3.64%
|
|
2021-03-31
|
-0.46
|
-0.25
|
0.21
|
45.65%
|
|
2020-12-31
|
-0.56
|
-0.53
|
0.03
|
5.36%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.66
|
|
2021-12-31
|
-1.89
|
|
2020-12-31
|
-2.08
|
|
2019-12-31
|
-1.81
|
|
2018-12-31
|
-13.31
|